Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears

Thyroid

Volumn 22, Issue 10, 2012, Pages 1025-1030

  Ferraz, Carolina ^a,b   Rehfeld, Christian ^a   Krogdahl, Annelise ^c   Precht Jensen, Eva Magrethe ^c   Bösenberg, Eileen ^a   Narz, Frank ^d   Hegedüs, Laszlo ^c   Paschke, Ralf ^a   Eszlinger, Markus ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d QIAGEN GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN RET; TRANSCRIPTION FACTOR PAX8;

AIR DRIED FINE NEEDLE ASPIRATION SMEAR; ARTICLE; CANCER DIAGNOSIS; CANCER TISSUE; DIAGNOSTIC ACCURACY; FEASIBILITY STUDY; GENE AMPLIFICATION; GENE REARRANGEMENT; GENETIC VARIABILITY; GOITER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RNA EXTRACTION; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; BIOPSY, FINE-NEEDLE; CARCINOMA; GENE REARRANGEMENT; HUMANS; ONCOGENE PROTEINS, FUSION; PAIRED BOX TRANSCRIPTION FACTORS; PPAR GAMMA; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-RET; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA; THYROID NEOPLASMS;

EID: 84866989940     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0391     Document Type: Article

References (26)

1. Hegedus L 2004 Clinical practice. The thyroid nodule. N Engl J Med 351:1764-1771.
2. Paschke R, Hegedus L, Alexander E, Valcavi R, Papini E, Gharib H 2011 Thyroid nodule guidelines: agreement, disagreement and need for future research. Nat Rev Endocrinol 7:354-361.
3. Ferraz C, Eszlinger M, Paschke R 2011 Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. J Clin Endocrinol Metab 96:2016-2026.
4. Giusti F, Falchetti A, Franceschelli F, Marini F, Tanini A, Brandi ML 2010 Thyroid cancer: current molecular perspectives. J Oncol 2010:351679; DOI: 10.1155/2010/351679.
5. Kondo T, Ezzat S, Asa SL 2006 Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6:292-306.
6. Nikiforova MN, Nikiforov YE 2009 Molecular diagnostics and predictors in thyroid cancer. Thyroid 19:1351-1361.
7. Placzkowski KA, Reddi HV, Grebe SK, Eberhardt NL, McIver B 2008 The role of the PAX8/PPARgamma fusion oncogene in thyroid cancer. PPAR Res 2008:672829; DOI: 10.1155/2008/672829.
8. Cantara S, Capezzone M, Marchisotta S, Capuano S, Buso-nero G, Toti P, Di Santo A, Caruso G, Carli AF, Brilli L, Montanaro A, Pacini F, Montanaro A 2010 Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab 95:1365-1369.
9. Cheung CC, Carydis B, Ezzat S, Bedard YC, Asa SL 2001 Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer. J Clin En-docrinol Metab 86:2187-2190. (Pubitemid 32472938)
10. Salvatore G, Giannini R, Faviana P, Caleo A, Migliaccio I, Fagin JA, Nikiforov YE, Troncone G, Palombini L, Basolo F, Santoro M 2004 Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab 89:5175-5180. (Pubitemid 39391466)
11. Zhu Z, Ciampi R, Nikiforova MN, Gandhi M, Nikiforov YE 2006 Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity. J Clin Endocrinol Metab 91:3603-3610. (Pubitemid 44402144)
12. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN 2009 Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 94:2092-2098.
13. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-142.
14. Algeciras-Schimnich A, Milosevic D, McIver B, Flynn H, Reddi HV, Eberhardt NL, Grebe SK 2010 Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis. Clin Chem 56:391-398.
15. Eszlinger M, Paschke R 2010 Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Mol Cell Endo-crinol 322:29-37.
16. Moses W, Weng J, Sansano I, Peng M, Khanafshar E, Ljung BM, Duh QY, Clark OH, Kebebew E 2010 Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy. World J Surg 11:2589-2594.
17. Nikiforova MN, Biddinger PW, Caudill CM, Kroll TG, Ni-kiforov YE 2002 PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol 26:1016-1023. (Pubitemid 34810562)
18. Castro P, Rebocho AP, Soares RJ, Magalhaes J, Roque L, Trovisco V, Vieira de Castro, I, Cardoso-de-Oliveira M, Fonseca E, Soares P, Sobrinho-Simoes M 2006 PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin En-docrinol Metab 91:213-220. (Pubitemid 43069140)
19. Marques AR, Espadinha C, Catarino AL, Moniz S, Pereira T, Sobrinho LG, Leite V 2002 Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 87:3947-3952. (Pubitemid 34879553)
20. Musholt TJ, Fottner C, Weber MM, Eichhorn W, Pohlenz J, Musholt PB, Springer E, Schad A 2010 Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules. World J Surg 11:2595-2603.
21. Unger K, Zitzelsberger H, Salvatore G, Santoro M, Bogda-nova T, Braselmann H, Kastner P, Zurnadzhy L, Tronko N, Hutzler P, Thomas G 2004 Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. J Clin Endocrinol Metab 89:4272-4279. (Pubitemid 39244425)
22. Guerra A, Sapio MR, Marotta V, Campanile E, Rossi S, Forno I, Fugazzola L, Budillon A, Moccia T, Fenzi G, Vitale M 2012 The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. J Clin Endo-crinol Metab 97:517-524.
23. Arora N, Scognamiglio T, Zhu B, Fahey TJ, III 2008 Do benign thyroid nodules have malignant potential? An evidence-based review. World J Surg 32:1237-1246.
24. Dwight T, Thoppe SR, Foukakis T, Lui WO, Wallin G, Hoog A, Frisk T, Larsson C, Zedenius J 2003 Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors. J Clin Endo-crinol Metab 88:4440-4445. (Pubitemid 37153755)
25. Fusco A, Chiappetta G, Hui P, Garcia-Rostan G, Golden L, Kinder BK, Dillon DA, Giuliano A, Cirafici AM, Santoro M, Rosai J, Tallini G 2002 Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. Am J Pathol 160:2157-2167. (Pubitemid 34663407)
26. Kim CS, Zhu X 2009 Lessons from mouse models of thyroid cancer. Thyroid 19:1317-1331.